Viscum Album for TNBC on Adjuvant Pembrolizumab
- Status
- RECRUITING
- Phase
- PHASE4
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs
- Status
- RECRUITING
- Phase
- PHASE1
Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer
- Status
- RECRUITING
- Phase
- NA
NeoCARD: Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Microbiome Immunotherapy Neoadjuvant Assessment
- Status
- RECRUITING
- Phase
- N/A
Different Methods of Capecitabine in Patients With Non-PCR After Neoadjuvant Therapy for TNBC
- Status
- RECRUITING
- Phase
- N/A
A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
De-escalation of Neoadjuvant Chemotherapy Regimens With Immunotherapy Among TNBC
- Status
- RECRUITING
- Phase
- N/A
Atezolizumab and Chemotherapy Treatment as T-cell Activators in Metastatic Triple Negative Breast Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Breast Cancer Evolution During Neoadjuvant Systemic Therapy
- Status
- RECRUITING
- Phase
- N/A
Cellular Immune Responses in Triple-negative Breast Cancer - High Throughput Immunogenetic Studies
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Neoadjuvant Toripalimab Plus Docetaxel and Carboplatin in Patients With Localized TNBC (NeoTOP)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
TNBC Gut Microbiota During Neoadjuvant Treatment
- Status
- WITHDRAWN
- Phase
- NA
Neoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Breast Cancer PSMA PET
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies
- Status
- RECRUITING
- Phase
- PHASE1